story of the week
Cisplatin-Based IP Chemotherapy Associated With Improved Survival in BRCA1+ Ovarian Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
British Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
BRCA1 Expression and Improved Survival in Ovarian Cancer Patients Treated With Intraperitoneal Cisplatin and Paclitaxel: A Gynecologic Oncology Group Study
Br. J. Cancer 2013 Mar 05;[EPub Ahead of Print], JL Lesnock, KM Darcy, C Tian, et alFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.